Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Testing effectiveness (Phase 2)Looking for participantsNCT06498986
What this trial is testing

BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 40
Large-scale testing (Phase 3)UnknownNCT05661240
What this trial is testing

Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 348
Testing effectiveness (Phase 2)Study completedNCT00004924
What this trial is testing

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yale University 28
Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)WithdrawnNCT06064279
What this trial is testing

Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC

Who this might be right for
Stage IV NSCLC
VA Office of Research and Development
Testing effectiveness (Phase 2)Looking for participantsNCT05789082
What this trial is testing

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 320
Testing effectiveness (Phase 2)Study completedNCT01344824
What this trial is testing

Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 38
Not applicableEnded earlyNCT00444223
What this trial is testing

Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center 3
Early research (Phase 1)Active Not RecruitingNCT06542731
What this trial is testing

An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Docetaxel and Ramucirumab as Second-line Therapy in Patients With Advanced or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Ono Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT01708954
What this trial is testing

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 125
Testing effectiveness (Phase 2)Looking for participantsNCT04606446
What this trial is testing

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic ER+ HER2- Breast CancerLocally Advanced or Metastatic Castration-resistant Prostate CancerLocally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer 320
Testing effectiveness (Phase 2)Looking for participantsNCT06517953
What this trial is testing

Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations

Who this might be right for
Non-small Cell Lung Cancer MetastaticEGFR G719XEGFR L861Q+1 more
Sun Yat-sen University 23
Testing effectiveness (Phase 2)Looking for participantsNCT06917573
What this trial is testing

PALACE: Cemiplimab Trial According to ctDNA Levels

Who this might be right for
Non Small Cell Lung Cancer MetastaticLung DiseasesStage IV Non-small Cell Lung Cancer+3 more
Fundación GECP 63
Testing effectiveness (Phase 2)Study completedNCT03023423
What this trial is testing

Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 100
Early research (Phase 1)Looking for participantsNCT05452005
What this trial is testing

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticBrain Metastases+1 more
University of California, Davis 20
Testing effectiveness (Phase 2)UnknownNCT03085069
What this trial is testing

Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms Nec+4 more
Jiangsu HengRui Medicine Co., Ltd. 146
Not applicableStudy completedNCT04804137
What this trial is testing

Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study

Who this might be right for
Non-squamous Lung CancerMetastatic Lung Cancer
University Hospital, Tours 24
Testing effectiveness (Phase 2)Looking for participantsNCT05242965
What this trial is testing

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
University of Washington 40
Next Page